Founder of Biotech Firm Actelion Named World Entrepreneur Of The Year 2008
Filed in archive Corporate and Industrial News on June 5, 2008
Ernst & Young has named Jean-Paul Clozel, founder of Switzerland-based biotech firm Actelion Pharmaceuticals Ltd., as the World Entrepreneur Of The Year 2008. Founded in 1997, Actelion develops small-molecule drugs for the treatment of pulmonary disease.
"Being named Ernst & Young World Entrepreneur Of The Year 2008 is a great honor for me and my team", said Clozel. "To be singled out from such a strong field of entrepreneurs makes us very proud."
"It's amazing how quickly Jean-Paul has built Actelion from nothing to a market capitalization of nearly €4 billion in a highly competitive and complex sector," said Greg Ericksen, Ernst & Young's Global Vice Chair for Strategic Growth Markets. "His vision and passion have enabled him to become one of the biotechnology industry's most recognized global success stories."
Read more here.
"It's amazing how quickly Jean-Paul has built Actelion from nothing to a market capitalization of nearly €4 billion in a highly competitive and complex sector," said Greg Ericksen, Ernst & Young's Global Vice Chair for Strategic Growth Markets. "His vision and passion have enabled him to become one of the biotechnology industry's most recognized global success stories."
Tags: entrepreneur biotech actelion pharma 2008 world+entrepreneur biotech+firm year+2008
Vote for Founder of Biotech Firm Actelion Named World Entrepreneur Of The Year 2008:
|
Rating: 6.80 out of 5 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells